|
Mechanism5-HT4 receptor antagonists |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
A Proof of Biological Efficacy Study Assessing the Potential of Piboserod, a Specific 5-HT4 Antagonist, for the Treatment of Symptomatic Congestive Heart Failure on Top of Usual Evidence Based Pharmacological Treatment
The purpose of this study is to determine whether piboserod, a serotonin-4 receptor antagonist, is effective for the treatment of patients with congestive heart failure.
/ Not yet recruitingNot Applicable A Proof of Biological Efficacy Study Assessing the Potential of Piboserod a Specific 5-HT4 Antagonist for the Treatment of Symptomatic Congestive Heart Failure in stable outpatients NYHA class II-III on top of Usual Evidence Based Pharmacological treatment
100 Clinical Results associated with Bio Medisinsk Innovasjon AS
0 Patents (Medical) associated with Bio Medisinsk Innovasjon AS
100 Deals associated with Bio Medisinsk Innovasjon AS
100 Translational Medicine associated with Bio Medisinsk Innovasjon AS